v3.26.1
Common Stock Options
9 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Common Stock Options

Note 11 – Common Stock Options

 

Stock Incentive Plan

 

On June 21, 2016, we amended and restated our 2012 Stock Incentive Plan (the “2012 Plan”), which was originally adopted on March 5, 2012, and terminated on March 5, 2022. As amended, the 2012 Plan provided for the issuance of up to 11,500,000 shares of common stock pursuant to the grant of options or other awards, including stock grants, to employees, officers or directors of, and consultants to, the Company and its subsidiaries. Options granted under the 2012 Plan may either be intended to qualify as incentive stock options under the Internal Revenue Code of 1986, or may be non-qualified options, and are exercisable over periods not exceeding ten years from date of grant.

 

 

Common Stock Option Issuances

 

There were no issuances of common stock options during the nine months ended June 30, 2026.

 

Amortization of Stock-Based Compensation

 

A total of $16,731 and $5,760 of stock-based compensation expense was recognized during the nine months ended June 30, 2026 and 2025, respectively, as a result of the vesting of common stock options issued in prior periods. As of June 30, 2026 no additional amounts of unamortized expense remains to be amortized over the vesting period.

 

The following is a summary of information about the stock options outstanding at June 30, 2026.

 

 

Shares Underlying Options Outstanding   Shares Underlying Options Exercisable 
        Weighted            
    Shares   Average  Weighted   Shares   Weighted 
Range of   Underlying   Remaining  Average   Underlying   Average 
Exercise   Options   Contractual  Exercise   Options   Exercise 
Prices   Outstanding   Life  Price   Exercisable   Price 
$.0056-0.13    7,920,000   2.37 years  $0.051    7,920,000   $0.051 

 

The following is a summary of activity of outstanding common stock options:

  

       Weighted 
       Average 
   Number   Exercise 
   of Shares   Price 
Balance, September 30, 2025   13,920,000   $0.062 
Options issued   -    - 
Options forfeited   (6,000,000)   (0.08)
           
Balance, June 30, 2026   7,920,000   $0.051 
           
Exercisable, June 30, 2026   7,920,000   $0.051 

 

As of June 30, 2026, these options in the aggregate had $15,540 of intrinsic value for the outstanding and exercisable options, based on the per share market price of $0.013 of the Company’s common stock as of such date was greater than the weighted-average exercise price of some of these options.